Pluristem Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $50,623,000.

Profit Margin

Pluristem Therapeutics Inc. (NASDAQ:PSTI): Profit margin
2012 716K -14.79M -2066.2%
2013 679K -21.15M -3115.61%
2014 379K -26.93M -7106.07%
2015 379K -24.67M -6511.08%
2016 2.84M -23.24M -816.51%
2017 0 -27.81M
2018 50K -26.12M -52252%
2019 54K -35.30M -65383.33%
2020 23K -29.15M -126747.83%
2021 0 -49.86M

PSTI Income Statement (2012 โ€“ 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
023K54K50K02.84M379K379K679K716K
Cost of revenue
002K2K0100K13K11K20K0
Gross profit
023K52K48K02.74M366K368K659K716K
Operating exp.
Research and development
30.06M21.57M26.42M22.62M21.09M19.58M19.17M19.54M17.23M9.17M
Selling and marketing
0000000000
Total operating expenses
50.62M29.49M35.58M33.77M28.01M26.06M25.63M28.21M22.88M15.74M
Operating income
-50.62M-29.47M-35.53M-33.73M-28.01M-23.31M-25.26M-27.85M-22.22M-15.03M
Other income (expenses), net
758K324K225K7.60M205K73K590K918K1.06M237K
Income before tax
-49.86M-29.15M-35.30M-26.12M-27.81M-23.24M-24.67M-26.93M-21.15M-14.79M
Income tax expense
836K520K225K7.60M205K73K590K918K1.09M0
Net income
-49.86M-29.15M-35.30M-26.12M-27.81M-23.24M-24.67M-26.93M-21.15M-14.79M
Earnings per share
Basic EPS
-1.77-1.6-2.86-2.47-3.18-2.92-3.51-4.24-3.81-3.4
Diluted EPS
-1.77-1.6-2.86-2.47-3.18-2.92-3.51-4.24-3.81-3.4
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source